KBC Group’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-158,664
Closed -$2.16M 1336
2020
Q4
$2.16M Buy
158,664
+41,742
+36% +$102K ﹤0.01% 1052
2020
Q3
$354K Sell
116,922
-76,410
-40% -$244K ﹤0.01% 1041
2020
Q2
$562K Sell
193,332
-30,682
-14% -$97K ﹤0.01% 946
2020
Q1
$632K Buy
224,014
+25,781
+13% +$83.1K 0.01% 816
2019
Q4
$643K Hold
198,233
﹤0.01% 1035
2019
Q3
$428K Sell
198,233
-55,547
-22% -$148K ﹤0.01% 1121
2019
Q2
$797K Buy
253,780
+85,826
+51% +$278K 0.01% 920
2019
Q1
$625K Buy
167,954
+87,862
+110% +$297K 0.01% 1020
2018
Q4
$232K Sell
80,092
-232,652
-74% -$639K ﹤0.01% 1106
2018
Q3
$823K Sell
312,744
-40,706
-12% -$99.9K 0.01% 978
2018
Q2
$827K Buy
353,450
+21,500
+6% +$60K 0.01% 861
2018
Q1
$976K Buy
331,950
+11,494
+4% +$31.4K 0.01% 788
2017
Q4
$878K Buy
320,456
+206,272
+181% +$634K 0.01% 844
2017
Q3
$387K Buy
114,184
+86,071
+306% +$239K ﹤0.01% 1013
2017
Q2
$69K Sell
28,113
-19,162
-41% -$44.1K ﹤0.01% 1226
2017
Q1
$107K Buy
+47,275
New +$105K ﹤0.01% 1249
2016
Q1
Sell
-456,616
Closed -$1.62M 1352
2015
Q4
$1.62M Buy
456,616
+13,229
+3% +$55.4K 0.03% 509
2015
Q3
$2.23M Buy
443,387
+22,044
+5% +$126K 0.04% 410
2015
Q2
$2.71M Buy
421,343
+13,284
+3% +$89K 0.03% 465
2015
Q1
$2.87M Sell
408,059
-363,602
-47% -$2.63M 0.04% 437
2014
Q4
$5.95M Buy
771,661
+233,811
+43% +$1.85M 0.07% 319
2014
Q3
$4.02M Sell
537,850
-2,893
-0.5% -$26.9K 0.14% 203
2014
Q2
$5.23M Buy
540,743
+293,470
+119% +$2.62M 0.06% 377
2014
Q1
$2.06M Buy
247,273
+30,697
+14% +$263K 0.03% 494
2013
Q4
$1.83M Buy
+216,576
New +$1.83M 0.03% 532

Other funds holding PDLI